Morphine- and cocaine-induced conditioned place preference: Effects of quinpirole and preclamol

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 2, 1996, Pages 371-375

  Kivastik, Toomas ^a,b   Vuorikallas, Kati ^a   Piepponen, T Petteri ^a   Zharkovsky, Alexander ^a,b   Ahtee, Liisa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

Cocaine; DA autoreceptors; Morphine; Place preference; Preclamol; Quinpirole; Rats; Reward

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MORPHINE; PRECLAMOL; QUINPIROLE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC CORTEX; MALE; MORPHINE ADDICTION; MOTIVATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029927116     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02052-7     Document Type: Article

References (39)

1. Arnt, J. Differential behavioural effects of dopamine agonists in developing rats: A study of 3-PPP enantiomers. Eur. J. Pharmacol. 91:273-278; 1983.
2. Bozarth, M. A.; Wise, R. A. Heroin reward is dependent on a dopaminergic substrate. Life Sci. 29:1881-1886; 1981.
3. Bull, D. R.; Sheenan, M. J. Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: A pharmacological study using fast cyclic voltammetry in vitro. Naunyn Schmiedebergs Arch. Pharmacol. 343:260-265; 1991.
4. 3 dopamine receptors. Science 260:1814-1816; 1993.
5. 2 receptor function in rats. J. Pharmacol. Exp. Ther. 266:586-592; 1993.
6. Carlsson, A. Receptor mediated control of dopamine metabolism. In: Usdin, E.; Bunney, W. E., eds. Pre- and postsynaptic receptors. New York: Marcel Dekker; 1975:49-65.
7. Clark, D.; Hjorth, S.; Carlsson, A. Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity. I. Review of evidence. J. Neural Transm. 62:1-52; 1985.
8. Clark, D.; Hjorth, S.; Carlsson, A. Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J. Neural Transm. 62:171-207; 1985.
9. Colpaert, F. C.; Niemegeers, J. E.; Janssen, P. A. J. Discriminative stimulus of cocaine: Neuropharmacological characteristics as derived from from stimulus generalization experiment. Pharmacol. Biochem. Behav. 10:535-546; 1979.
10. 3 dopamine receptor agonist 7-OH-DPAT in relation to other "D2-like" agonists. Neuropharmacology 32:509-510; 1993.
11. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278; 1988.
12. Ettenberg, A.; Pettit, H. O.; Bloom, F. E.; Koob, G. F. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems. Psychopharmacology (Berlin) 78:204-209; 1982.
13. 1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology (Berlin) 114:486-494; 1994.
14. Hemby, S. E.; Jones, G. H.; Hubert, G. W.; Neill, D. B.; Justice, Jr. Assessment of the relative contribution of peripheral and central components in cocaine place conditioning. Pharmacol. Biochem. Behav. 47:973-979; 1994.
15. 2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences. Prog. Neuropsychopharmacol. Biol. Psychiatry 12:315-322; 1988.
16. 1 function. A behavioural and biochemical study. Naunyn Schmiedebergs Arch. Pharmacol. 340: 355-365; 1989.
17. Kosten, T. A.; Nestler, E. J. Clozapine attenuates cocaine conditioned place preference. Life Sci. 55:PL9-14; 1994.
18. 1 receptors by SCH23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 135:251-254; 1987.
19. Loh, E. A.; Fitsch, T. S.; Vickers, G.; Roberts, D. C. S. Clozapine increases breaking points on a progressive-ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 42: 559-562; 1992.
20. Mackey, W. B.; van der Kooy, D. Neuroleptics block the positive reinforcing effect of amphetamine but not of morphine as measured by place preference conditioning. Pharmacol. Biochem. Behav. 22:101-105; 1985.
21. Martin-Iverson, M. T.; Ortmann, R.; Fibiger, H. C. Place conditioning with methylphenidate and nomifensine. Brain Res. 332: 59-67; 1985.
22. Matthews, R. T.; German, D. C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11:617-625; 1984.
23. Morency, M. A.; Beninger, R. J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399:33-41; 1986.
24. Nakajima, S.; Wise, R. A. Heroin self-administration in the rat suppressed by SCH23390. Soc. Neurosci. Abstr. 13:1545; 1987.
25. Pettit, H. O.; Ettenberg, A.; Bloom, F. E.; Koob, G. F. Destruction of dopamine in nucleus accumbens selectively attenuates cocaine but not heroin self-administration. Psychopharmacology (Berlin) 84:167-173; 1984.
26. Roberts, D. C. S; Corcoran, M. E.; Fibiger, H. C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6:615-620; 1977.
27. Roberts, D. C. S.; Koob, G. F.; Klonoff, P.; Fibiger, H. C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:781-787; 1979.
28. 2 receptor agonists and antagonist. Neuropharmacology 30:1269-1274; 1991.
29. 2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:53-59; 1993.
30. Smith, J. E.; Guerin, G. F.; Conchita, C. O.; Barr, T. S.; Lane, J. D. Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self-administration. Pharmacol. Biochem. Behav. 23:843-849; 1985.
31. Sokoloff, P.; Giros, B.; Marets, M.-P.; Bouthenet, M.-L.; Schwartz, J.-Ch. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-151; 1990.
32. Spyraki, C.; Fibiger, H. C.; Phillips, A. G. Attenuation of heroin reward by disruption of the mesolimbic dopamine system Psychopharmacology (Berlin) 79:278-283; 1982a.
33. Spyraki, C.; Fibiger, H. C.; Phillips, A. G. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 253:195-203; 1982.
34. Spyraki, C.; Nomikos, G. G.; Varonos, D. D. Intravenous cocaine-induced place preference: Attenuation by haloperidol. Behav. Brain Res. 26:57-62; 1987.
35. White, F. J.; Wang, R. Y. Pharmacological characterization of dopamine autoreceptors in rat ventral tegmental area: Microiontophoretic studies. J. Pharmacol. Exp. Ther. 231:275-280; 1984.
36. 2 dopamine receptors in the rat nucleus accumbens. J. Neurosci. 6:274-280; 1986.
37. 2 agonists injected peripherally or into nucleus accumbens. Psychopharmacology (Berlin) 103:271-276; 1991
38. Widzowski, D. V.; Gori-Slechta, D. A. Apparent mediation of stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors. J. Pharmacol. Exp. Ther. 266:526-534; 1993.
39. Yokel, R. A. Intravenous self-administration: Response rates, the effects of pharmacological challenges, and drug preference. In: Bozarth, M. A., ed. Methods of assessing the reinforcing properties of abused drugs. Berlin: Springer; 1987:1-33.